Michael D. Clayman Insider Trading $AKBA Akebia Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Michael D. Clayman.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Michael D. Clayman. Michael D. Clayman is President and CEO in Flexion Therapeutics Inc ($FLXN) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA).

Michael D. Clayman in Akebia Therapeutics, Inc.

Trading Symbol: AKBA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael D. Clayman:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 15 2018
$AKBA Market Capitalization: $177.33M
$AKBA Previous Close: $9.88

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Michael D. Clayman in Akebia Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AKBA, FLXN

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 15 2018AKBAAkebia Therapeutic ...Clayman Michael D.Option ExerciseA11.1412,500139,25012,500
Jun 19 2017AKBAAkebia Therapeutic ...Clayman Michael D.Option ExerciseA14.3712,500179,62512,500
Jun 20 2016AKBAAkebia Therapeutic ...Clayman Michael D.Option ExerciseA8.5612,500107,00012,500
Jun 12 2015AKBAAkebia Therapeutic ...Clayman Michael D.DirectorOption ExerciseA7.865,00039,3005,000

Page:   1